Showing results (1-10 of 771) with videos related to
Sort By:
Pageof 78
Kidney Research and Clinical Practice|March 31, 2022
Exploring molecular targets in diabetic kidney diseaseSayako Maruno, Tetsuhiro Tanaka, Masaomi Nangaku[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 10, 2021
[Renal anemia and hypoxia-inducible factor prolyl hydroxylase inhibitor]Sayako Maruno, Tetsuhiro Tanaka, Masaomi NangakuContributions to Nephrology|January 22, 2011
Pathogenesis of tubular interstitial nephritisTetsuhiro Tanaka, Masaomi NangakuJournal of Pharmacological Sciences|January 20, 2009
Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKDTetsuhiro Tanaka, Masaomi NangakuCurrent Opinion in Nephrology and Hypertension|September 26, 2009
The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney diseaseTetsuhiro Tanaka, Masaomi NangakuExperimental Cell Research|March 15, 2012
Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agentsTetsuhiro Tanaka, Masaomi NangakuNature Reviews. Nephrology|March 6, 2013
Angiogenesis and hypoxia in the kidneyTetsuhiro Tanaka, Masaomi NangakuKidney International|May 3, 2014
ANO1: an additional key player in cyst growthTetsuhiro Tanaka, Masaomi NangakuCurrent Opinion in Nephrology and Hypertension|July 9, 2011
The role of incretins in salt-sensitive hypertension: the potential use of dipeptidyl peptidase-IV inhibitorsTetsuhiro Tanaka, Masaomi Nangaku, Akira NishiyamaAmerican Journal of Physiology. Renal Physiology|October 29, 2014
Hypoxia as a key player in the AKI-to-CKD transitionShinji Tanaka, Tetsuhiro Tanaka, Masaomi NangakuPageof 78